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ABSTRACT 
 
DNA molecules have been used as generic instead of genetic materials to construct 
nanostructures. Based on Watson-Crick base pairing, a three-arm junction DNA, or Y-
shaped DNA (Y-DNA), was first synthesized from three partially complementary 
oligonucleotides as a basic building block. Each Y-DNA consists of three non-
palindromic sticky ends so that it could ligate to other DNA building blocks to form 
desired nanostructures and DNA hydrogel. 
The goal of this work was to utilize DNA hydrogel as a protein drug delivery system. 
In previous work, we created DNA hydrogels that had good swelling abilities, 
controlled degradation rates and were cytocompatible. In the present studies, we 
characterized the release of two model proteins, insulin and bovine serum albumin 
(BSA), from DNA hydrogels. A numerical simulation of the whole release system 
based on a FEM method was achieved. These initial studies indicate that DNA 
hydrogels are suitable for delivering proteins for controlled drug delivery and tissue 
engineering. 
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CHAPTER 1 
Introduction: Branched DNA Molecules and DNA 
Hydrogel 
 
 
 
 
 
 
 
 
 
 
 
 
1 1.1   Branched DNA molecules 
DNA molecules are well known as genetic information carriers and the core of the 
central dogma. A naturally existing DNA molecule is an either linear or circular 
polymer with a backbone of alternating phosphate and carbon sugar (deoxyribose), 
which is attached to a base, adenine (A), guanine (G), cytosine (C), or thymine (T). A 
single-stranded DNA (ssDNA) is chemically polar with a 5’ phosphorylated end (the 
phosphate group on the 5’ carbon of the sugar ring) and 3’ hydroxyl end (the hydroxyl 
group on the 3’ carbon of the sugar ring). The presence of chemically active 5’ 
phosphate and 3’ hydroxyl functional groups offer great possibility to functionalize 
DNA with many chemical entities, including proteins, fluorochromes, and metals. Use 
of nucleic acids as generic materials instead of genetic materials has sparked much 
research interest in recent years.  Many DNA nanotechnology advances have been 
made by Seeman and colleagues, including the creation of various geometric objects, 
periodic frameworks, arrays, and scaffolds using ‘double crossover’ DNA
1. Other 
progress has also been made with linear DNA in developing systems such as biotin-
avidin based gene networks, DNA conjugated Au nanocrystals, DNA-templated Au 
wires, and hybrid DNA-protein nanocomplexes
1, 4, 5. However, all these advances have 
utilized linear DNA, restricting their effectiveness in molecular constructions
1. To 
overcome this limitation, DNA building blocks of different shapes must be 
constructed with the ability to be incorporated into larger schemes in a controlled 
manner
1.  
In 2004, Luo and colleagues created a new DNA building block in the shape of the 
letter Y
2. These Y-DNA building blocks are designed to have specific sticky ends, 
allowing them to specifically and covalently attach to other Y-DNAs in a controlled 
and enzyme-catalyzed means
2. When the Y-DNAs are specifically attached to each 
other, they form a multivalent and anisotropic dendrimer-like structure, named 
2 dendrimer-like DNA (DL-DNA; Figure 1.1)
2.  
There are many possible applications for DL-DNA, including a potential drug carrier, 
a multi-gene therapy vector, and a DNA nanobarcode
1, 2, 3.   
In a similar manner, X-DNAs and T-DNAs can be synthesized from X-DNA building 
blocks and T-DNA building blocks, respectively. In 2006, Luo and colleagues created 
DNA hydrogels from branched DNA monomers (BDM)
3. DNA hydrogels were 
created using anisotropic DNA building blocks as shown in Figure 1.2. Different DNA 
hydrogels are possible to create because DNA building blocks can be different. Also 
the geometry and dimensions of DNA hydrogels can be exactly controlled (Figure 
1.3)
2.  
In this project, the potential of using DNA hydrogel as a drug carrier was explored, 
specifically for two protein drugs, insulin and bovine serum albumin (BSA).  
 
 
 
 
 
Figure 1.1. – (left) Schematic drawing of Y-shaped DNA. (middle) Actual single 
strand DNA sequences. (right) DL-DNA formed by four Y-shaped DNA building 
blocks
1.  
3  
 
 
Figure 1.2. Schematic Diagram of synthesis of different DNA hydrogels from X-DNA, 
Y-DNA, and T-DNA building blocks, respectively
2. 
 
 
 
4  
Figure 1.3.  Hydrogels made entirely from branched DNA.  a, A swollen X-DNA 
hydrogel fabricated in a cylindrical mould. The size is 7.0 mm in diameter and 3.0 mm 
in height. The scale bar is 1 cm. The inset shows the DNA gel stained with SYBR I. 
b, Images of dried (left) and swollen (right) X-DNA hydrogels with different patterns: 
rectangular, circular, triangular, star and cross (from the top left corner, clockwise). 
The scale bars are 1 cm. c, X-DNA gels patterned in CORNELL shapes at centimetre 
scale (top and middle rows; the scale bar is 1 cm) and micrometre scale (bottom row; 
the scale bar is 500 µm). They were stained with two different, DNA-specific 
fluorescent dyes: ethidium bromide (red, the middle row) and SYBR I (green, the 
bottom row). 
5 1.2 DNA hydrogel 
A hydrogel is a three-dimensional polymer network of hydrophilic polymer chains 
that are crosslinked through either chemical or physical bonding. Because of the 
hydrophilic nature of polymer chains, hydrogels absorb water to swell in the presence 
of abundant water. The swelling process is the same as the dissolution of non-
crosslinked hydrophilic polymers. By definition, water constitutes at least 10% of the 
total weight (or volume) of a hydrogel. When the content of water exceeds 95% of the 
total weight (or volume), the hydrogel is called a superabsorbent. Because measuring 
the weight of a swelling hydrogel is much easier than measuring the volume, the 
swelling ratio of hydrogels is usually expressed based on weights.  In a chemical 
hydrogel, all polymer chains are crosslinked to each other by covalent bonds, and thus, 
the hydrogel is one molecule regardless of its size. For this reason, there is no concept 
of molecular weight of hydrogels, and hydrogels are sometimes called infinitely large 
molecules or supermacromolecules. One of the unique properties of hydrogels is their 
ability to maintain original shape during and after swelling due to isotropic swelling.  
Hydrogels have been used widely in the development of biocompatible biomaterials, 
and this is mainly due to the low interfacial tension and low frictional surface by the 
presence of water on the surface. The dried hydrogels (also called xerogels) are 
usually clear, and swelling in water takes a long time. The slow swelling process is 
due to slow diffusion of water through the compact polymer chains. It is this slow 
swelling property that has been useful in controlled drug delivery. For a glassy 
hydrogel of a size equivalent to a stack of five pennies, it will take hours before the 
hydrogel shows appreciable swelling.  
Hydrogels are very versatile materials and have attracted significant attention recently 
as drug delivery systems. In addition to their inertness and good compatibility, the 
6 ability of hydrogels to release an entrapped drug in an aqueous medium and the ease 
of regulating such drug release make hydrogels particularly suitable as drug carriers 
for the controlled release of pharmaceuticals. First, there is no need to remove residual 
biomaterials from the implant site to improve tissue compatibility. Secondly, 
biodegradable hydrogels allow a wider range of drug release profiles and hence more 
versatile. Therefore, a biodegradable hydrogel delivery system appears to be one of 
the most promising approaches for protein delivery. Biodegradable hydrogels would 
permit then entrapped proteins to be released in a controlled manner through both drug 
diffusion and hydrogel degradation. Such a combination of diffusion and degradation 
controlled mechanisms may provide us with the desirable release kinetics of proteins 
that have a wide range of molecular sizes. 
Several strategies and materials have been employed as hydrogel drug delivery 
systems for protein drugs. For instance, synthetic biodegradable polymers, such as 
poly (lactide-glycolides) (PLG) or polyanhydrides can be used for controlled release 
of pharmaceutical substances including bioactive macromolecules. Due to the use of 
organic solvents, incorporation of biologically active molecules into these hydrogel 
systems often results in their inactivation. Recently, DNA hydrogels have been made
3. 
These DNA hydrogels have been synthesized in a mild condition and they have been 
shown to be biodegradable, biocompatible and non-toxic to mammalian cells. In 
addition, DNA hydrogels have great swelling abilities and moderate mechanical 
properties. These make DNA hydrogels as very interesting controlled release systems. 
The purpose of the present study was to evaluate the in vitro release kinetics of protein 
drugs from different DNA hydrogels in order to understand the mechanism of release 
and explore the potential application of DNA hydrogels as drug delivery systems.  In 
this study, we chose insulin and bovine serum albumin (BSA) as the model proteins. 
Due to its importance for therapeutic use in a large and expanding market, insulin has 
7 been the focus of intensive research in both academia and industry. Especially The 
challenge of administering insulin orally has been addressed over the last several 
decades with a view to helping ease the pain and stress caused during insulin 
injections by the millions of diabetic patients worldwide
6.  BSA is a well-studied 
protein that has been used as a model for controlled release of proteins from hydrogel 
systems. It is inexpensive, easy to assay and generally available.  
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CHAPTER 2 
Materials and Methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 2.1 Materials  
Porcine insulin (Mw 5770) and bovine serum albumin (BSA, Mw 68,000) were 
purchased from Sigma Chemicals (St. Louis, MO). DNA oligonucleotides were 
purchased from IDTDNA (USA). Insulin and BSA solutions were prepared by 
dissolving the protein powder in milli Q water with designed weight ratio (w/w). 
 
Table 2.1 Sequence of Oligonucleotides 
 
 
 
 
 
 
 
11 Table 2.2 Properties of insulin and BSA 
 
 Molecular  Weight
(Dalton) 
Hydrodynamic Radius 
(nm) 
Solubility in Water
(mg/ml) 
Insulin Monomer  5770   1.3   1  
BSA Monomer  68000  3.7  40  
 
 
2.2 Methods 
2.2.1 Preparation of BDM and DNA hydrogel 
BDM were designed and synthesized according to the procedures described 
previously
1.  
In brief, X-DNA was constructed by mixing three oligonucleotide components (1:1:1 
molar ratio) in sterile Milli-Q water with a final concentration of 5 mM for each 
oligonucleotide. Hybridizations were performed according to the following procedures: 
(i) 
Denaturation at 95 °C for 2 min. (ii) Cooling at 65 °C and incubation for 5 min. (iii) 
Annealing at 60 °C for 2 min. (iv) Further annealing at 60 °C for 0.5 min with a 
continuous temperature decrease at a rate of 1 °C per min. The annealing steps were 
repeated a total of 40 times. The final annealed products were stored at 4 °C. 
DNA hydrogels were synthesized according to the procedures described previously
2. 
In brief, to construct an X-DNA gel, branched X-DNA molecules were designed and 
synthesized, in such a way that each arm of the X-DNA molecule possessed a 
complementary sticky end whose sequences were palindromic. Thus, these branched 
X-DNA molecules were able to hybridize to and ligate with each other via T4 DNA 
12 ligase, serving as both monomers and crosslinkers. The self-assembly of branched X-
DNA monomers (BDM) coupled with ligase-catalysed reactions led to a large-scale, 
three-dimensional structure that had the properties of a hydrogel. Each X-DNA 
molecule was ligated with Weiss unites of T4 DNA ligase (Promega). The reaction 
was carried out at room temperature overnight on a gentle rotator.   
 
2.2.2 Hydrogel protein release 
To characterize the release of model proteins from DNA hydrogels, 0.1% (w/v) insulin 
and bovine serum albumin (BSA) stock solutions were added in the gelation solution 
prior to crosslinking. We cross-linked 200 µl of gelation solution in 6-mm diameter, 
15-mm deep mold (Company). After overnight gentle shaking, the completely-formed 
hydrogels were carefully transferred to empty 1.5 ml polypropylene tubes. 
After all of the hydrogels were synthesized, they were washed by adding 0.5 ml of 
phosphate buffered saline (PBS) to the tubes for 3 times. After washing, 0.5 ml of PBS 
was added to each tube as the release buffer. The tubes were mixed at 50 rpm at 20 °C. 
At specified sample collection times, 0.5 ml of solution was transferred to a 1.5 ml 
centrifuge tube and the tube was replenished with 0.5 ml fresh PBS. 
For Insulin, the protein content of each sample was analyzed with the Porcine ELISA 
kit (ALPCO Diagnostics). For BSA, the protein content of each sample was analyzed 
with the Bio-Rad protein assay using the mircroassay procedure. Triplicate hydrogels 
were analyzed in each trial. 
 
 
 
 
 
13 2.2.3 Computer simulation  
To have a mechanistic understanding of the release process, a diffusion model of the 
protein release through the gel was developed. Figure 3.10 shows a schematic of the 
system with the boundary conditions. Proteins are assumed to diffuse to the boundary 
and get convected away by the release buffer. The removal by the release buffer is 
assumed to be symmetric. The governing equation for diffusion in an axisymmetric 
cylindrical geometry is  
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                                         (2.1) 
Here c is protein concentration; r and z are radial and axial coordinates, respectively. T 
is time of release. R and H are radius and height of cylinder, respectively, and D is the 
diffusivity of protein drugs, in the hydrogel, which can be function of concentration. 
The release buffer, having zero concentration of proteins, is replaced at two day 
intervals and is agitated, leading to the boundary condition 
0 ) ( = = R r c                                                                             (2.2) 
Symmetry at the center leads to the following boundary condition at the center 
0 ) 0 ( = =
∂
∂
r
r
c
                                                                          (2.3) 
At the top and bottom of the cylinder, 
0 ) 0 ( = = z c                                                                              (2.4) 
0 ) ( = = H z c                                                                             (2.5) 
Initial protein concentration in the hydrogel is C0, 
0 ) 0 , , ( c t z r c = =                                                                       (2.6) 
The governing equation and boundary conditions were solved in finite element 
computational software COMSOL (COMSOL, USA). Rectangular elements were 
14 used. The number of elements was increased until it did not affect the solution (called 
mesh convergence). A total of 625 elements were used for the final computation. 
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CHAPTER 3 
Results and Conclusions 
 
 
 
 
 
 
 
 
 
 
 
 
 
17  
3.1 Results 
In the one-pot approach, equal moles of all three oligonucleotides were mixed well 
together to form Y-DNA. The formation of Y-DNA was evaluated by gel 
electrophoresis (Figure 3.1), in which the mobility of a DNA molecule depends on its 
size, shape and extent of base pairing. One major band of each lane appeared on the 
gel (Figure 3.1A, lane 7), and its mobility was less than that of its components, the 
single-stranded DNA (Figure 3.1A, lane 6), indicating the formation of one arm of Y-
DNA. The further shift of the mobility of the final annealing product of one-pot 
synthesis (Figure 3.1A lane 8) indicated the formation of Y-DNA. Similar results were 
obtained from the one-pot synthesis of X-DNA and T-DNA.  
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Figure 3.1. BDM Syntheses. (A) Evaluation of X0-DNA and Y0-DNA by 3% agarose 
gel. Lanes 1 is 25 bp DNA ladder. Lane 2 is oligonucleotide X0a.Lanes 3 is the 
hybridized products of X0a and X0b. Lane 4 is the hybridized products of X0a, X0b and 
X0c. Lanes 5 is hybridized final products of (X0a, X0b, X0c  and X0d). Lane 6 is 
oligonucleotide Y0a  Lane 7 is hybridized products of (Y0a and Y0b) Lane 8 is 
hybridized final products of (Y0a, Y0b and Y0c). (B) Evaluation of T0-DNA by 3% 
agarose gel. Lane 1 is oligonucleotide T0a. Lane 2 is hybridized products of T0a and T0b. 
Lane 3 is hybridized final products of T0a, T0b, and T0c. Lane 4 is 25 bp DNA ladder. 
Lane 5 is oligonucleotide X0a. Lanes 6 is the hybridized products of X0a and X0b. Lanes 
7 is hybridized final products of (X0a, X0b and X0c). 
 
19  
BDM synthesized were used to synthesize DNA hydrogels, following the methods 
described above. 
It has been shown that X-Gel swells the most, while Y-Gel and T-Gel swell similarly 
but less than X-Gel. These can be seen from the DNA hydrogel images shown in 
Figure 3.2. While all the DNA hydrogels are cylindrical and have the same diameter, 
X-Gel has the largest height, approximately 6 mm, compared to about 3 mm for Y-Gel 
and T-Gel. The difference in swelling is possibly due to the different molecular 
structure of these gels. 
The dimensions of DNA hydrogels, as well as their volumes and surface areas, are 
summarized in Table 3.1. As X-Gel swells the most and thus has the largest height, it 
also has the largest volume and surface area, compared with Y-Gel and T-Gel.  
The loading efficiency was deduced from the amounts of effectively incorporated and 
initially introduced proteins. As can be seen from Figure 3.3 and Figure 3.4, no 
significant difference among different DNA hydrogels was observed for the loading 
efficiencies of insulin and BSA, respectively. Compared to the loading efficiencies of 
insulin into DNA hydrogels, the loading efficiencies of BSA into DNA hydrogels are 
significantly lower compared with insulin. This is possibly due to the higher molecular 
weight and larger size of BSA. Also as insulin has a solubility of about 1 mg/ml in 
water at room temperature, BSA has a much higher solubility of 40 mg/ml. Thus BSA 
tends to stay more in the PBS buffer than insulin. 
Insulin release experiments were conducted in a study period of 32 days. Smooth 
release curves were obtained, as can be seen from Figure 3.5. In particular, the release 
of insulin was dependent on the types of BDM. After 7 days, about 40%, 35% and 
30% of insulin were release from Y-, T- and X-DNA gels, respectively. The total 
amount of insulin released within 32 days was 55%, 50% and 45% for Y-, T- and X-
DNA gels, respectively. 
20  
 
 
 
 
Figure 3.2. DNA hydrogels. (A) X-Gel (B) Y-Gel (C) T-Gel 
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Table 3.1. Dimensions of DNA hydrogels 
 
 
Height 
(mm) 
Diameter 
(mm) 
Volume 
(mm
3) 
Surface Area 
(cm
2) 
X-Gel 6.0  6.0  166  1.53 
Y-Gel 3.0  6.0  83  1.12 
T-Gel 3.0  6.0  83  1.12 
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Figure 3.3. Loading efficiencies of insulin into different DNA hydrogels. The left, 
middle, and right bars are representing X-Gel, Y-Gel, and T-Gel, respectively. The 
error bars represent standard deviation from three or more replicates. 
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Figure 3.4. Loading efficiency of BSA into different DNA hydrogels. The left, middle, 
and right bars are representing X-Gel, Y-Gel, and T-Gel, respectively. The error bars 
represent standard deviation from three or more replicates. 
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BSA release experiments were conducted in a study period of 22 days. Although there 
was burst effect detected especially of Y- and T-DNA gels, smooth release curves 
were obtained, as can be seen from Figure 3.6. In particular, the release of BSA was 
dependent on the types of BDM. After 7 days, about 60%, 60% and 50% of BSA were 
release from Y-, T- and X-DNA gels, respectively. The total amount of BSA released 
within 22 days was 75%, 75% and 60% for Y-, T- and X-DNA gels, respectively.  
The release difference may be attributed to and thus can be controlled by the structural 
variations in the DNA gels.  
 
 
 
Figure 3.5. Controlled insulin release profiles of different DNA hydrogels. The 
diamonds, squares and triangles indicate X-, Y- and T-DNA gels. The error bars 
represent standard deviation from three or more replicates. 
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Figure 3.6. Controlled BSA release profiles of different DNA hydrogels. The 
diamonds, squares and triangles indicate X-, Y- and T-DNA gels. The error bars 
represent standard deviation from three or more replicates. 
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In order to investigate the mechanism of release, accumulated release amount is 
plotted against the square root of time. Figure 3.7 and Figure 3.8 show there is almost 
a linear relationship between accumulated release percentage of insulin and BSA, and 
the t
1/2 for the first week, respectively. This indicates the release is almost diffusion-
controlled. The decrease in release rate in the following two weeks may due to the 
insufficient pathways for the release of insulin and BSA encapsulated deeply inside 
the hydrogels. 
Incomplete release occurs when some of the drug particles are isolated, or completely 
surrounded by polymer. These drug molecules have no pathway to the surface. Large 
amount of insulin and BSA were still trapped inside the DNA hydrogels at the end of   
study period. Figure 3.9 shows after 32 days, about 30%, 20% and 20% of BSA were 
left in X-, Y-, and T- DNA gels, respectively. The leftover of insulin in X-, Y-, and T- 
DNA gels, respectively, are about 45%, 25% and 40%.This is possibly because the 
pore size formed upon swelling of the DNA hydrogels alone was not large enough for 
these large size proteins. The pore size of DNA hydrogels is at the nanometer scale 
and is supposed to around 13.2 nm theoretically. The hydrodynamic radius of insulin 
and BSA are 1.6 nm and 3.7 nm, respectively. Furthermore, it has been shown that 
insulin aggregates in aqueous solutions upon shaking. The pore size of DNA 
hydrogels may not be large enough for these insulin aggregates to pass through. 
A schematic drawing of a cylindrical X-Gel used in the computer simulation is shown 
in Figure 3.10. The dimensions of Y-Gel and T-Gel used in the simulation would be 
the same as X-Gel, except that the height of Y-Gel and T-Gel is 3 mm, instead of 6 
mm for X-Gel. As noted above, the crucial step in the simulation process is to 
calculate the amount of protein drugs inside DNA hydrogels at certain time points. 
This is done by calculating the concentration of the drugs, assuming there is a constant 
volume for DNA hydrogels. 
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Figure 3.7. Cumulative release (%) of insulin from DNA hydrogels is proportional to 
the square root of time up to about 45% protein release. The diamonds, squares and 
triangles indicate X-, Y- and T-DNA gels. The error bars represent standard deviation 
from three or more replicates. 
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Figure 3.8. Cumulative release (%) of BSA from DNA hydrogels is proportional to 
the square root of time up to about 60% protein release. The diamonds, triangles and 
squares indicate X-, Y- and T-DNA gels. The error bars represent standard deviation 
from three or more replicates. 
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Figure 3.9. Amount of insulin and BSA left in DNA hydrogels after 32 days. Black 
bars represent the amount of BSA remaining in DNA hydrogels while white bars 
represent the amount of insulin remaining in DNA hydrogels. 
 
 
 
 
 
 
30  
 
 
 
 
 
 
 
Symmetry
Boundary
R=3 mm
Hydrogel
H=6 mm
Buffer
Symmetry
Boundary
R=3 mm
Hydrogel
H=6 mm
Buffer
 
Figure 3.10. A schematic of a cylindrical X-Gel used in the simulation, showing 
dimensions and boundary conditions. 
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Figure 3.11. Computer simulation of BSA release from T-Gel. The diamonds and 
squares indicate experimental release data of T-DNA gel and computer simulation for 
T-DNA gel, respectively. 
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Figure 3.11 shows the results of FEM solution to equation (2.1). Figure 3.11 shows the 
simulation agrees well with the experimental data of BSA release from T-DNA gel for 
the first week. Other simulation results also showed good agreement with the release 
experiment data for the first week for both insulin and BSA (data not shown). This 
confirms the mechanism for the release in the first week is diffusion controlled. 
However the diffusion model can not be applied to the entire study period of 32 days 
for insulin and 22 days for BSA, Figure 3.12 shows apparent discrepancy remains 
between the simulation and the experimental data of insulin release from Y-Gel after 
the first week.  Other simulation results also showed discrepancy between the 
simulation and the experimental data (data not shown). 
 
Figure 3.12. Computer simulation of insulin release from Y-Gel. The diamonds and 
squares indicate experimental release data of Y-DNA gel and computer simulation for 
Y-DNA gel, respectively.
1
                                                 
1 The optimization work starting on this page and continuing for the following four pages, including 
Figure 3.13, is the work of Dr. E. Balsa-Canto and Dr. J. Banga of the Process Eng. Group, I.I.M.- 
C.S.I.C, C/Eduardo Cabello 6, 36208, Vigo, Spain.. 
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Since a constant diffusivity of proteins in the gel could not explain the release profiles, 
a varying diffusivity with concentration was tried.  An optimization procedure was 
used to arrive at a diffusivity variation with concentration that best describes the 
measured data.  For the optimization, numerical method of lines was used.  Second 
order formulas with a discretization level of 11x11 were used as a first guess.  The 
resulting set of ordinary differential equations (ODEs) is solved using a stiff ODE 
solver RADAU5
5. The coarse grid of 11x11 was needed to reduce computational time 
since a large number of model evaluations were required.  Refined solutions were 
calculated on a finer grid (15x15).  For optimization, a global method
6 is used. 
A quadratic variation of diffusivity with concentration, c, provided good fit of the 
predictions with experimental data but, when extrapolated beyond the range used in 
the optimization process, predicted negative diffusivities for low concentrations.   
Therefore, an exponential variation in diffusivity with concentration, of the form 
was used instead.  For the three gels, diffusivity variation given in 
Eqn.(3.1) provided the least sum of squares computed between measured release and 
the release predicted by the model: 
2
1(1- e )
ac Da =
 
   (3.1) 
0.0785728
0.0722563
0.073535
-0.000301201(1- ) for X-gel
-0.00120246(1- ) for Y-gel
-0.00062646(1- ) for T-gel
c
c
c
e
De
e
⎧
⎪ = ⎨
⎪
⎩
Comparison between measured and the predicted release for the above diffusivities are 
shown in Figure 3.13. 
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Figure 3.13.  Measured release (points) and predicted release (solid lines) for the 
diffusivity variations with concentration shown in Eqn.(3.1), for X-gel, Y-gel and T-
gel, respectively. 
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To improve understanding of these diffusivity variations with concentration in terms 
of their magnitudes and relative variations in different gels, relationships in Eqn.(3.1) 
are plotted in Figure 3.14.  From this figure for diffusion of insulin, X-Gel has the 
smallest diffusivity while compared to Y-Gel and T-Gel.  It has been shown that 
among the three types of DNA hydrogels, X-Gel has the largest tensile modulus and is 
most resistant to degradation
3. This is possibly due to the unique molecular structure 
of X-Gel as each X-DNA building block has four arms which could be cross-linked to 
other X-DNA building blocks, compared to the three arms of Y-DNA and T-DNA 
building blocks. This not only makes X-Gel much stronger, but more difficult for the 
proteins drugs to diffuse through. 
 
 
 
 
Figure 3.14. Concentration-dependent diffusivities of insulin in DNA hyrogels 
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3.2 Discussions 
A useful method of comparing the protein release from different hydrogel materials is 
to calculate the effective diffusion coefficient, De. We found that there are significant 
decreases in De of insulin and BSA in these DNA hydrogels compared to the infinite-
dilution diffusion coefficients, D0. For insulin, our simulation showed its diffusivities 
in DNA hydrogels are approximately  m
11 10 1
− ×
2/s, which is smaller than the reported 
infinite dilution diffusivity  m
11 10 7 . 7
− ×
2/s
7. 
Our experimental findings showed that the De of BSA was generally larger than that of 
insulin. One possible reason for this may be attributed to the higher solubility of BSA 
in water (40 mg/mL) than that of insulin (1 mg/mL). Another possible reason is 
increasing protein size increases the rate of protein release. The size of the proteins in 
the matrix affects the size of the water-filled channels formed as the particle dissolve. 
Larger particles occupy more volume in a matrix, increasing the pore-to-pore 
connectivity. Increased connectivity provides simpler pathways (i.e., less tortuous and 
less constricted pathways) for diffusion of protein drugs. As the hydrodynamic radius 
of BSA monomer is about 3.7 nm, while insulin monomer has a hydrodynamic radius 
of about 1.3 nm, it is possible that this size difference would have an effect on the 
diffusivity difference between BSA and insulin in DNA hydrogels. 
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4.1 Conclusions 
In conclusion, three types of DNA hydrogels have been synthesized. Release 
characteristics of two protein drugs, insulin and BSA, have been studied. Over one 
month period, smooth release curves have been observed. The release kinetics is 
dependent on the type of DNA hydrogel. X-Gel has the slowest release rate for both 
insulin and BSA. 
The release mechanism of insulin and BSA from DNA hydrogels were appropriately 
and simply described by the diffusion model in the first week. The diffusion model 
would not be able to describe the release profiles after the first week. This is possibly 
due to the degradation of DNA hydrogels and aggregation of proteins inside DNA 
hydrogels. An exponential fit using a concentration-dependent diffusivity provided 
good agreement between the simulation and the experimental data. 
DNA hydrogels can be easily tuned to have different molecular structures at the 
nanometer scale and various sizes in the macroscale range. They can be ideal 
candidates for biodegradable, biocompatible and controlled drug delivery systems. 
Considering the availability of a vast number of enzymes that can manipulate DNA at 
angstrom scale, our results strongly suggest that DNA can be engineered as a designer 
material whose properties can be more easily tuned. These biodegradable, 
biocompatible, DNA hydrogels are a new class of materials that can be exploited in a 
variety of biomedical applications including sustained drug delivery, tissue 
engineering, 3D cell culture, cell transplant therapy and other biomedical applications
1. 
Future work includes using dynamic light scattering to study insulin aggregation under 
the same experimental conditions. Different sizes and shapes of DNA hydrogels can 
also be tuned to optimize the release characteristics of these protein drugs. 
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41 APPENDIX A 
Encapsulation Efficiency of Protein Drugs in DNA Hydrogels 
 
Insulin 
Average 
Encapsulation Standard
Efficiency Deviation
X-Gel 93.12 5.125781
Y-Gel 95.08 3.085023
T-Gel 90.03 7.140198  
 
BSA 
Average
Encapsulation Standard
Efficiency Deviation
X-Gel 80.66 5.20781
Y-Gel 73.83 4.20311
T-Gel 72.09 8.16798  
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APPENDIX B 
Accumulated Release Percentage of Protein Drugs from DNA Hydrogels 
Insulin 
Square X-Gel X-Gel Y-Gel Y-Gel T-Gel T-Gel
Root of Accumulated Standard Accumulated Standard Accumulated Standard
Day Time % Deviation % Deviation % Deviation
00 0 0 0 0 0 0
1 1 6.483333 1.52902 10.490000 1.39689 7.41666667 0.61158
3 1.73205 15.086667 1.78215 25.560000 3.5921 18.4833333 1.67837
5 2.23607 22.976667 2.96380 36.5366667 3.69635 27.770000 2.48387
7 2.64575 29.696667 3.00976 41.6666667 3.57878 34.810000 3.60529
12 3.4641 35.173330 2.67489 47.2866667 4.12835 41.0866667 2.39061
17 4.12311 39.830000 4.80392 50.0166667 4.58839 44.6366667 2.83507
22 4.69042 41.916667 1.09501 51.9866667 5.03613 46.8933333 4.10968
27 5.19615 43.426667 2.99367 53.7833333 5.04256 48.4133333 2.94376
32 5.65685 44.223330 1.57233 54.680000 4.79832 48.8533333 2.68683  
 
BSA 
Square X-Gel X-Gel Y-Gel Y-Gel T-Gel T-Gel
Day Root of Accumulated Standard Accumulated Standard Accumulated Standard
Time % Deviation % Deviation % Deviation
00 0 0 0 0 0 0
1 1 19.68 3.8925442 29.6433333 4.4189856 29.6433333 4.418986
3 1.732 32.60333333 4.37788 43.9933333 5.470003 45.2 3.002466
5 2.236 45.57666667 4.4128336 56.9133333 6.8867288 57.4866667 5.952515
7 2.646 52.68666667 3.713655 64.3266667 6.9859597 65.6233333 5.986989
12 3.464 59.52 2.7923168 71.5866667 7.6453406 72.0366667 3.743158
22 4.69 62.60333333 2.2601401 75.9733333 7.6357864 73.86 4.544128  
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APPENDIX C 
Remaining Percentage of Protein Drugs in DNA Hydrogels 
 
Insulin 
Remaining Standard
Percentage Deviation
X-Gel 43.85 4.16
Y-Gel 26.36 9.29
T-Gel 40.82 4.78  
 
 
BSA 
Remaining Standard
Percentage Deviation
X-Gel 29.04 5.94
Y-Gel 19.02 7.81
T-Gel 19.95 7.20  
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